Évaluation des médicaments

Overview of ecallantide in the treatment of hereditary angioedema types I and II

Erin Banta and Timothy J Craig

• Abstrait

Évaluation des médicaments

Micafungin in a nutshell: state of affairs on the pharmacological and clinical aspects of the novel echinocandin

Fedja Farowski, Jorg J Vehreschild, Oliver A Cornely and Maria JGT Vehreschild

• Abstrait

Cour de rapport

Neuro-QOL and the NIH Toolbox: implications for epilepsy

Cindy J Nowinski, David Victorson, Jose E Cavazos, Richard Gershon and David Cella

• Abstrait

Cour de rapport

Post-traumatic epilepsy: an overview

Rebecca M Verellen and Jose E Cavazos

• Abstrait

Article de révision

Antiepileptic drug pregnancy registries: do the latest findings concur?

Leticia Tornes and Cynthia L Harden

• Abstrait

Article de révision

Neuropsychiatric issues in patients with epilepsy: focus on depression

Taoufik Alsaadi

• Abstrait

Article de révision

Approach to refractory childhood seizures

Blathnaid McCoy and Selim R Benbadis

• Abstrait

Article de révision

Efficacy of electrical brain stimulation in epilepsy

Peter Widdess-Walsh, Christoph Kellinghaus, Eric Geller, Frank Bosebeck, Stephan Schuele and Tobias Loddenkemper

• Abstrait

Article de révision

Surgical approaches to epilepsy

Aabir Chakraborty and James T Rutka

• Abstrait

Évaluation des médicaments

Lacosamide for the treatment of partial-onset seizures

Matthew H Wong and Nathan B Fountain

• Abstrait